In 2019, a group of researchers reported that the exosomal miR-20a-5p from breast cancer cells could stimulate osteoclast proliferation and differentiation by targeting SRC kinase signaling inhibitor 1 (SRCIN1), a kinase involved in cell migration [124]. This evidence concerns the gene SRCIN1 and breast carcinoma.